"Nashville's Premier Headache Specialists! Our practice is known for its modern, integrative approach to the treatment of complicated headache syndromes – including migraine. At NNG, our compassionate physicians are experts in diagnosing and treating migraines, as well as a variety of primary and secondary headache syndromes, with two main priorities: YOU and YOUR HEALTH. We understand that migraines and other headache syndromes can be a significant cause of disability - both at work, and in your personal life. Together we will work to effectively diagnose and tailor your treatment to meet your needs as an individual. We are dedicated to providing excellent, comprehensive headache care and helping you find relief from your pain."

During the past decade, Nashville Neuroscience Group conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nashville Neuroscience Group" #1 sponsor was "Amgen" with 3 trials, followed by "Allergan" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "AEON Biopharma, Inc." with 1 trials sponsored and "Boston Scientific Corporation" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nashville Neuroscience Group" #1 collaborator was "Clinvest" with 1 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Nashville Neuroscience Group" are "Migraine" (6 trials), "Migraine Headache" (2 trials), "Migraine With Aura" (2 trials), "Migraine, With or Without Aura" (2 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Nashville Neuroscience Group" in a lesser frequency.

Most popular intervention types in "Nashville Neuroscience Group" are "Drug" (15 trials), "Device" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "ABP-450" (1 trials), "AMG334" (1 trials), "Active Transcranial Magnetic Stimulation (TMS) Device" (1 trials) and "Atogepant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nashville Neuroscience Group" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Nashville Neuroscience Group". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Nashville Neuroscience Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Nashville Neuroscience Group, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".